메뉴 건너뛰기




Volumn 232, Issue 1-3, 2013, Pages 11-15

Parenteral buprenorphine-naloxone abuse is a major cause of fatal buprenorphine-related poisoning

Author keywords

Abuse liability; Buprenorphine; Drug abuse; Fatal poisoning; Naloxone; Urine analysis

Indexed keywords

BUPRENORPHINE; BUPRENORPHINE PLUS NALOXONE; NALOXONE; NORBUPRENORPHINE;

EID: 84880740918     PISSN: 03790738     EISSN: 18726283     Source Type: Journal    
DOI: 10.1016/j.forsciint.2013.06.017     Document Type: Article
Times cited : (30)

References (45)
  • 2
    • 0017204772 scopus 로고
    • Clinical use of buprenorphine in chronic administration
    • Adriaensen H., Van De Walle J. Clinical use of buprenorphine in chronic administration. Acta Anaesthesiol. Belg. 1976, 27:187-191.
    • (1976) Acta Anaesthesiol. Belg. , vol.27 , pp. 187-191
    • Adriaensen, H.1    Van De Walle, J.2
  • 4
    • 0018147760 scopus 로고
    • Human pharmacology and abuse potential of the analgesic buprenorphine: a potential agent for treating narcotic addiction
    • Jasinski D.R., Pevnick J.S., Griffith J.D. Human pharmacology and abuse potential of the analgesic buprenorphine: a potential agent for treating narcotic addiction. Arch. Gen. Psychiatry 1978, 35:501-516.
    • (1978) Arch. Gen. Psychiatry , vol.35 , pp. 501-516
    • Jasinski, D.R.1    Pevnick, J.S.2    Griffith, J.D.3
  • 6
    • 0042360208 scopus 로고    scopus 로고
    • Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone
    • Fudala P.J., Bridge T.P., Herbert S., Williford W.O., Chiang C.N., Jones K., et al. Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone. N. Engl. J. Med. 2003, 349:949-958.
    • (2003) N. Engl. J. Med. , vol.349 , pp. 949-958
    • Fudala, P.J.1    Bridge, T.P.2    Herbert, S.3    Williford, W.O.4    Chiang, C.N.5    Jones, K.6
  • 7
    • 0034704453 scopus 로고    scopus 로고
    • Buprenorphine and naloxone co-administration in opiate-dependent patients stabilized on sublingual buprenorphine
    • Harris D.S., Jones R.T., Welm S., Upton R.A., Lin E., Mendelson J. Buprenorphine and naloxone co-administration in opiate-dependent patients stabilized on sublingual buprenorphine. Drug Alcohol Depend. 2000, 61:85-94.
    • (2000) Drug Alcohol Depend. , vol.61 , pp. 85-94
    • Harris, D.S.1    Jones, R.T.2    Welm, S.3    Upton, R.A.4    Lin, E.5    Mendelson, J.6
  • 8
    • 0037987960 scopus 로고    scopus 로고
    • Clinical and pharmacological evaluation of buprenorphine and naloxone combinations: why the 4:1 ratio for treatment?
    • Mendelson J., Jones R.T. Clinical and pharmacological evaluation of buprenorphine and naloxone combinations: why the 4:1 ratio for treatment?. Drug Alcohol Depend. 2003, 70:S29-S37.
    • (2003) Drug Alcohol Depend. , vol.70
    • Mendelson, J.1    Jones, R.T.2
  • 9
    • 77955940327 scopus 로고    scopus 로고
    • Buprenorphine in the treatment of opiate dependence
    • Wesson D.R., Smith D.E. Buprenorphine in the treatment of opiate dependence. J. Psychoactive Drugs 2010, 42:161-175.
    • (2010) J. Psychoactive Drugs , vol.42 , pp. 161-175
    • Wesson, D.R.1    Smith, D.E.2
  • 10
    • 79954558512 scopus 로고    scopus 로고
    • Buprenorphine and buprenorphine/naloxone diversion, misuse, and illicit use: an international review
    • Yokell M.A., Zaller N.D., Green T.C., Rich J.D. Buprenorphine and buprenorphine/naloxone diversion, misuse, and illicit use: an international review. Curr. Drug Abuse Rev. 2011, 4:28-41.
    • (2011) Curr. Drug Abuse Rev. , vol.4 , pp. 28-41
    • Yokell, M.A.1    Zaller, N.D.2    Green, T.C.3    Rich, J.D.4
  • 11
    • 0035885323 scopus 로고    scopus 로고
    • Deaths involving buprenorphine: a compendium of French cases
    • Kintz P. Deaths involving buprenorphine: a compendium of French cases. Forensic Sci. Int. 2001, 121:65-69.
    • (2001) Forensic Sci. Int. , vol.121 , pp. 65-69
    • Kintz, P.1
  • 12
    • 84857042995 scopus 로고    scopus 로고
    • Benzodiazepines and alcohol are associated with cases of fatal buprenorphine poisoning
    • Häkkinen M., Launiainen T., Vuori E., Ojanperä I. Benzodiazepines and alcohol are associated with cases of fatal buprenorphine poisoning. Eur. J. Clin. Pharmacol. 2012, 68:301-309.
    • (2012) Eur. J. Clin. Pharmacol. , vol.68 , pp. 301-309
    • Häkkinen, M.1    Launiainen, T.2    Vuori, E.3    Ojanperä, I.4
  • 13
    • 84862683744 scopus 로고    scopus 로고
    • Toxicological and pathological findings in a series of buprenorphine related deaths. Possible risk factors for fatal outcome
    • Seldén T., Ahlner J., Druid H., Kronstrand R. Toxicological and pathological findings in a series of buprenorphine related deaths. Possible risk factors for fatal outcome. Forensic Sci. Int. 2012, 220:284-290.
    • (2012) Forensic Sci. Int. , vol.220 , pp. 284-290
    • Seldén, T.1    Ahlner, J.2    Druid, H.3    Kronstrand, R.4
  • 14
    • 0027203690 scopus 로고
    • The misuse of buprenorphine and a buprenorphine-naloxone combination in Wellington, New Zealand
    • Robinson G.M., Dukes P.D., Robinson B.J., Cooke R.R., Mahoney G.N. The misuse of buprenorphine and a buprenorphine-naloxone combination in Wellington, New Zealand. Drug Alcohol Depend. 1993, 33:81-86.
    • (1993) Drug Alcohol Depend. , vol.33 , pp. 81-86
    • Robinson, G.M.1    Dukes, P.D.2    Robinson, B.J.3    Cooke, R.R.4    Mahoney, G.N.5
  • 15
    • 0034033451 scopus 로고    scopus 로고
    • Effects of buprenorphine versus buprenorphine/naloxone tablets in non-dependent opioid abusers
    • Strain E.C., Stoller K., Walsh S.L., Bigelow G.E. Effects of buprenorphine versus buprenorphine/naloxone tablets in non-dependent opioid abusers. Psychopharmacology (Berl.) 2000, 148:374.
    • (2000) Psychopharmacology (Berl.) , vol.148 , pp. 374
    • Strain, E.C.1    Stoller, K.2    Walsh, S.L.3    Bigelow, G.E.4
  • 16
    • 33947127824 scopus 로고    scopus 로고
    • Abuse liability of buprenorphine-naloxone tablets in untreated IV drug users
    • Alho H., Sinclair D., Vuori E., Holopainen A. Abuse liability of buprenorphine-naloxone tablets in untreated IV drug users. Drug Alcohol Depend. 2007, 88:75-78.
    • (2007) Drug Alcohol Depend. , vol.88 , pp. 75-78
    • Alho, H.1    Sinclair, D.2    Vuori, E.3    Holopainen, A.4
  • 17
    • 65549137670 scopus 로고    scopus 로고
    • Lack of reduction in buprenorphine injection after introduction of co-formulated buprenorphine/naloxone to the Malaysian market
    • Bruce R.D., Govindasamy S., Sylla L., Kamarulzaman A., Altice F.L. Lack of reduction in buprenorphine injection after introduction of co-formulated buprenorphine/naloxone to the Malaysian market. Am. J. Drug Alcohol Abuse 2009, 35:68-72.
    • (2009) Am. J. Drug Alcohol Abuse , vol.35 , pp. 68-72
    • Bruce, R.D.1    Govindasamy, S.2    Sylla, L.3    Kamarulzaman, A.4    Altice, F.L.5
  • 18
    • 77949411784 scopus 로고    scopus 로고
    • Abuse liability of intravenous buprenorphine/naloxone and buprenorphine alone in buprenorphine-maintained intravenous heroin abusers
    • Comer S.D., Sullivan M.A., Vosburg S.K., Manubay J., Amass L., Cooper Z.D., et al. Abuse liability of intravenous buprenorphine/naloxone and buprenorphine alone in buprenorphine-maintained intravenous heroin abusers. Addiction 2010, 105:709-718.
    • (2010) Addiction , vol.105 , pp. 709-718
    • Comer, S.D.1    Sullivan, M.A.2    Vosburg, S.K.3    Manubay, J.4    Amass, L.5    Cooper, Z.D.6
  • 19
    • 77955466653 scopus 로고    scopus 로고
    • Acute effects of intramuscular and sublingual buprenorphine and buprenorphine/naloxone in non-dependent opioid abusers
    • Duke A.N., Correia C.J., Walsh S.L., Bigelow G.E., Strain E.C. Acute effects of intramuscular and sublingual buprenorphine and buprenorphine/naloxone in non-dependent opioid abusers. Psychopharmacology (Berl.) 2010, 211:303-312.
    • (2010) Psychopharmacology (Berl.) , vol.211 , pp. 303-312
    • Duke, A.N.1    Correia, C.J.2    Walsh, S.L.3    Bigelow, G.E.4    Strain, E.C.5
  • 20
    • 79954515756 scopus 로고    scopus 로고
    • Illicit use of buprenorphine/naloxone among injecting and noninjecting opioid users
    • Bazazi A.R., Yokell M., Fu J.J., Rich J.D., Zaller N.D. Illicit use of buprenorphine/naloxone among injecting and noninjecting opioid users. J. Addict. Med. 2011, 5:175-180.
    • (2011) J. Addict. Med. , vol.5 , pp. 175-180
    • Bazazi, A.R.1    Yokell, M.2    Fu, J.J.3    Rich, J.D.4    Zaller, N.D.5
  • 21
    • 80053571601 scopus 로고    scopus 로고
    • Post-marketing surveillance of buprenorphine-naloxone in Australia: diversion, injection and adherence with supervised dosing
    • Larance B., Degenhardt L., Lintzeris N., Bell J., Winstock A., Dietze P., et al. Post-marketing surveillance of buprenorphine-naloxone in Australia: diversion, injection and adherence with supervised dosing. Drug Alcohol Depend. 2011, 118:265-273.
    • (2011) Drug Alcohol Depend. , vol.118 , pp. 265-273
    • Larance, B.1    Degenhardt, L.2    Lintzeris, N.3    Bell, J.4    Winstock, A.5    Dietze, P.6
  • 22
    • 84155164697 scopus 로고    scopus 로고
    • Diversion and abuse of buprenorphine: findings from national surveys of treatment patients and physicians
    • Johanson C., Arfken C.L., di Menza S., Schuster C.R. Diversion and abuse of buprenorphine: findings from national surveys of treatment patients and physicians. Drug Alcohol Depend. 2012, 120:190-195.
    • (2012) Drug Alcohol Depend. , vol.120 , pp. 190-195
    • Johanson, C.1    Arfken, C.L.2    di Menza, S.3    Schuster, C.R.4
  • 23
    • 84896404240 scopus 로고    scopus 로고
    • Urine naloxone concentration at different phases of buprenorphine maintenance treatment
    • (Epub ahead of print)
    • Heikman P., Häkkinen M., Gergov M., Ojanperä I. Urine naloxone concentration at different phases of buprenorphine maintenance treatment. Drug Test. Anal. 2013, (Epub ahead of print). 10.1002/dta.1464.
    • (2013) Drug Test. Anal.
    • Heikman, P.1    Häkkinen, M.2    Gergov, M.3    Ojanperä, I.4
  • 24
    • 69949101444 scopus 로고    scopus 로고
    • Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: risk factors and lives saved
    • Degenhardt L., Randall D., Hall W., Law M., Butler T., Burns L. Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: risk factors and lives saved. Drug Alcohol Depend. 2009, 105:9-15.
    • (2009) Drug Alcohol Depend. , vol.105 , pp. 9-15
    • Degenhardt, L.1    Randall, D.2    Hall, W.3    Law, M.4    Butler, T.5    Burns, L.6
  • 25
    • 56449112183 scopus 로고    scopus 로고
    • Urinary detection times and metabolite/parent compound ratios after a single dose of buprenorphine
    • Kronstrand R., Nyström I., Andersson M., Gunnarsson L., Hägg S., Josefsson M., et al. Urinary detection times and metabolite/parent compound ratios after a single dose of buprenorphine. J. Anal. Toxicol. 2008, 32:586-593.
    • (2008) J. Anal. Toxicol. , vol.32 , pp. 586-593
    • Kronstrand, R.1    Nyström, I.2    Andersson, M.3    Gunnarsson, L.4    Hägg, S.5    Josefsson, M.6
  • 26
    • 0031968220 scopus 로고    scopus 로고
    • Relationship of plasma buprenorphine and norbuprenorphine to withdrawal symptoms during dose induction, maintenance and withdrawal from sublingual buprenorphine
    • Kuhlman J.J., Levine B., Johnson R.E., Fudala P.J., Cone E.J. Relationship of plasma buprenorphine and norbuprenorphine to withdrawal symptoms during dose induction, maintenance and withdrawal from sublingual buprenorphine. Addiction 1998, 93:549-559.
    • (1998) Addiction , vol.93 , pp. 549-559
    • Kuhlman, J.J.1    Levine, B.2    Johnson, R.E.3    Fudala, P.J.4    Cone, E.J.5
  • 27
    • 2042470124 scopus 로고    scopus 로고
    • Pharmacokinetics and subjective effects of sublingual buprenorphine, alone or in combination with naloxone
    • Harris D.S., Mendelson J.E., Lin E.T., Upton R.A., Jones R.T. Pharmacokinetics and subjective effects of sublingual buprenorphine, alone or in combination with naloxone. Clin. Pharmacokinet. 2004, 43:329-340.
    • (2004) Clin. Pharmacokinet. , vol.43 , pp. 329-340
    • Harris, D.S.1    Mendelson, J.E.2    Lin, E.T.3    Upton, R.A.4    Jones, R.T.5
  • 28
    • 22244462451 scopus 로고    scopus 로고
    • Buprenorphine: clinical pharmacokinetics in the treatment of opioid dependence
    • Elkader A., Sproule B. Buprenorphine: clinical pharmacokinetics in the treatment of opioid dependence. Clin. Pharmacokinet. 2005, 44:661-680.
    • (2005) Clin. Pharmacokinet. , vol.44 , pp. 661-680
    • Elkader, A.1    Sproule, B.2
  • 29
    • 58149109889 scopus 로고    scopus 로고
    • Population pharmacokinetics of intravenous, intramuscular, and intranasal naloxone in human volunteers
    • Dowling J., Isbister G.K., Kirkpatrick C.M., Naidoo D., Graudins A. Population pharmacokinetics of intravenous, intramuscular, and intranasal naloxone in human volunteers. Ther. Drug Monit. 2008, 30:490-496.
    • (2008) Ther. Drug Monit. , vol.30 , pp. 490-496
    • Dowling, J.1    Isbister, G.K.2    Kirkpatrick, C.M.3    Naidoo, D.4    Graudins, A.5
  • 30
    • 84860391245 scopus 로고    scopus 로고
    • Preliminary buprenorphine sublingual tablet pharmacokinetic data in plasma, oral fluid, and sweat during treatment of opioid-dependent pregnant women
    • Concheiro M., Jones H.E., Johnson R.E., Choo R., Huestis M.A. Preliminary buprenorphine sublingual tablet pharmacokinetic data in plasma, oral fluid, and sweat during treatment of opioid-dependent pregnant women. Ther. Drug Monit. 2011, 33:619-626.
    • (2011) Ther. Drug Monit. , vol.33 , pp. 619-626
    • Concheiro, M.1    Jones, H.E.2    Johnson, R.E.3    Choo, R.4    Huestis, M.A.5
  • 31
    • 79959965800 scopus 로고    scopus 로고
    • The pharmacodynamic and pharmacokinetic profile of intranasal crushed buprenorphine and buprenorphine/naloxone tablets in opioid abusers
    • Middleton L.S., Nuzzo P.A., Lofwall M.R., Moody D.E., Walsh S.L. The pharmacodynamic and pharmacokinetic profile of intranasal crushed buprenorphine and buprenorphine/naloxone tablets in opioid abusers. Addiction 2011, 106:1460-1473.
    • (2011) Addiction , vol.106 , pp. 1460-1473
    • Middleton, L.S.1    Nuzzo, P.A.2    Lofwall, M.R.3    Moody, D.E.4    Walsh, S.L.5
  • 32
    • 80053570710 scopus 로고    scopus 로고
    • Gender differences in pharmacokinetics of maintenance dosed buprenorphine
    • Moody D.E., Fang W.B., Morrison J., McCance-Katz E. Gender differences in pharmacokinetics of maintenance dosed buprenorphine. Drug Alcohol Depend. 2011, 118:479-483.
    • (2011) Drug Alcohol Depend. , vol.118 , pp. 479-483
    • Moody, D.E.1    Fang, W.B.2    Morrison, J.3    McCance-Katz, E.4
  • 33
    • 0015758661 scopus 로고
    • Disposition of naloxone-7,8,3H in normal and narcotic-dependent men
    • Fishman J., Roffwarg H., Hellman L. Disposition of naloxone-7,8,3H in normal and narcotic-dependent men. J. Pharmacol. Exp. Ther. 1973, 187:575-580.
    • (1973) J. Pharmacol. Exp. Ther. , vol.187 , pp. 575-580
    • Fishman, J.1    Roffwarg, H.2    Hellman, L.3
  • 34
    • 70349873940 scopus 로고    scopus 로고
    • Determination of naloxone and nornaloxone (noroxymorphone) by high-performance liquid chromatography-electrospray ionization-tandem mass spectrometry
    • Fang W.B., Chang Y., McCance-Katz E.F., Moody D.E. Determination of naloxone and nornaloxone (noroxymorphone) by high-performance liquid chromatography-electrospray ionization-tandem mass spectrometry. J. Anal. Toxicol. 2009, 33:409-417.
    • (2009) J. Anal. Toxicol. , vol.33 , pp. 409-417
    • Fang, W.B.1    Chang, Y.2    McCance-Katz, E.F.3    Moody, D.E.4
  • 36
    • 84862621692 scopus 로고    scopus 로고
    • Patterns of free (unconjugated) buprenorphine, norbuprenorphine, and their glucuronides in urine using liquid chromatography-tandem mass spectrometry
    • McMillin G.A., Davis R., Carlisle H., Clark C., Marin S.J., Moody D.E. Patterns of free (unconjugated) buprenorphine, norbuprenorphine, and their glucuronides in urine using liquid chromatography-tandem mass spectrometry. J. Anal. Toxicol. 2012, 36:81-87.
    • (2012) J. Anal. Toxicol. , vol.36 , pp. 81-87
    • McMillin, G.A.1    Davis, R.2    Carlisle, H.3    Clark, C.4    Marin, S.J.5    Moody, D.E.6
  • 37
    • 0031655824 scopus 로고    scopus 로고
    • Six deaths linked to concomitant use of buprenorphine and benzodiazepines
    • Reynaud M., Petit G., Potard D., Courty P. Six deaths linked to concomitant use of buprenorphine and benzodiazepines. Addiction 1998, 93:1385-1392.
    • (1998) Addiction , vol.93 , pp. 1385-1392
    • Reynaud, M.1    Petit, G.2    Potard, D.3    Courty, P.4
  • 38
    • 33748553325 scopus 로고    scopus 로고
    • A survey of buprenorphine related deaths in Singapore
    • Lai S.H., Yao Y.J., Lo D.S.T. A survey of buprenorphine related deaths in Singapore. Forensic Sci. Int. 2006, 162:80-86.
    • (2006) Forensic Sci. Int. , vol.162 , pp. 80-86
    • Lai, S.H.1    Yao, Y.J.2    Lo, D.S.T.3
  • 40
    • 84865005087 scopus 로고    scopus 로고
    • Polydrug abuse: a review of opioid and benzodiazepine combination use
    • Jones J.D., Mogali S., Comer S.D. Polydrug abuse: a review of opioid and benzodiazepine combination use. Drug Alcohol Depend. 2012, 125:8-18.
    • (2012) Drug Alcohol Depend. , vol.125 , pp. 8-18
    • Jones, J.D.1    Mogali, S.2    Comer, S.D.3
  • 41
    • 84870253649 scopus 로고    scopus 로고
    • Respiratory toxicity of buprenorphine results from the blockage of P-glycoprotein-mediated efflux of norbuprenorphine at the blood-brain barrier in mice
    • Alhaddad H., Cisternino S., Declèves X., Tournier N., Schlatter J., Chiadmi F., et al. Respiratory toxicity of buprenorphine results from the blockage of P-glycoprotein-mediated efflux of norbuprenorphine at the blood-brain barrier in mice. Crit. Care Med. 2012, 40:3215-3223.
    • (2012) Crit. Care Med. , vol.40 , pp. 3215-3223
    • Alhaddad, H.1    Cisternino, S.2    Declèves, X.3    Tournier, N.4    Schlatter, J.5    Chiadmi, F.6
  • 45
    • 47749151132 scopus 로고    scopus 로고
    • A retrospective evaluation of patients switched from buprenorphine (Subutex) to the buprenorphine/naloxone combination (Suboxone)
    • Simojoki K., Vorma H., Alho H. A retrospective evaluation of patients switched from buprenorphine (Subutex) to the buprenorphine/naloxone combination (Suboxone). Subst. Abuse Treat. Prev. Policy 2008, 3:16.
    • (2008) Subst. Abuse Treat. Prev. Policy , vol.3 , pp. 16
    • Simojoki, K.1    Vorma, H.2    Alho, H.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.